Home
Storia in 2 fonti
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.
- ·
cnbc.com
Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer
Former Sen. Ben Sasse is taking Revolution Medicines' daraxonrasib, which has shown promise as a treatment for pancreatic cancer.
- ·
Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.
- ·
ilmessaggero.it
Tumore al pancreas, una nuova pillola raddoppia la sopravvivenza: ecco come funziona Daraxonrasib
Nuove speranze contro il tumore al pancreas da una pillola sperimentale che in fase 3, su pazienti con tumore metastatico, ha ottenuto un raddoppio della sopravvivenza rispetto…